A new study has identified a blood-cleansing procedure known as therapeutic apheresis as a potential game-changer in kidney transplant management, raising fresh hope for patients facing transplant ...

Travere Therapeutics Inc. (NASDAQ:TVTX) is one of the best small cap stocks with biggest upside potential. On August 10, Citi ...

Dimerix Limited ( ($AU:DXB) ) has issued an announcement. Dimerix Limited has released an updated investor presentation and video detailing the ...

Art in the Loft’s “SummerView” exhibit is on display now through Sept. 6 at 109 N. 2nd Ave. in Alpena. The gallery is open ...

Why Precision Funds Management's Dermot Woods takes a shine to biotechs that can explain their programs in simple terms.

Acadia Healthcare Company Inc. (NASDAQ: ACHC) is one of the best small cap stocks with biggest upside potential. On August 13 ...

With a solid cash position and expected profitability by late 2026, Apellis stock is set for recovery. Read the latest ...

Data show that diabetes-associated metabolic issues lead to kidney lipid accumulation, resulting in inflammation and fibrosis that cause progressive kidney damage and disease progression.Earlier data ...

Morgan's Scott Power highlights nine ASX healthcare companies from the 2025 Bioshares Biotech Summit with catalysts over next ...

MZE782 Phase 1 Trial in Healthy Volunteers to Provide Proof of Mechanism Data for Phenylketonuria (PKU) and Chronic Kidney ...

A group of medical researchers has identified a blood-cleansing procedure known as ‘therapeutic apheresis’ as an emerging game-changer in the management of kidney transplants, offering new hope to ...